AVBP SG&A Expense Growth
Arrivent Biopharma Inc · SG&A Expense Growth
AVBP SG&A Expense Growth
Latest reported58.02%period ending
AVBP FY SG&A Growth (YoY) (0.00% → 58.02%)
Latest values, visible window
High-resolution chart · PNG
AVBP sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 58.0175% | |
| 57.6757% | |
| 49.9459% | |
| 186.1627% | |
| 0% |